Publication dates

All regions

Immunotherapy Industry, September 2014 Market Research & Statistics

You might be interested in: vaccine, oncology, drug, more »

1-10 of about 900 reports for Immunotherapy

Alk - Annual Report, June 2014

  • Alk Releases its Annual Report 2013
  • June 2014
    73 pages
  • Denmark  

    Europe  

View report >

Pathology Description in Europe - Forecast

  • May 2014
    5 pages
  • Melanoma  

    Drug  

  • Europe  

    Italy  

    Germany  

View report >

Pathology Description in the US - Forecast

  • Umbrella Research
  • January 2012
    33 pages
  • Cancer  

    Crohn's Disease  

  • United States  

View report >

Pathology Description in the US - Forecast

  • Umbrella Research
  • January 2012
    33 pages
  • Cancer  

    Crohn's Disease  

  • United States  

View report >

General Medicine And Specialty Medicine Markets in the US - Forecast

  • March 7, 2014 Friday
  • March 2014
    10 pages
  • General Medicin...  

    Oncology  

    Pathology  

  • United States  

    Europe  

    Spain  

View report >

Pathology Description in the US

  • Proteasome Inhibitor Mln9708 Shows Promise
  • December 2012
    8 pages
  • Cancer  

  • United States  

View report >

General Medicine And Specialty Medicine Markets in the US - Forecast

  • Mci Daily Dose Equity Research Headlines: March 7, 2014
  • January 2014
    10 pages
  • General Medicin...  

    Oncology  

    Pathology  

  • United States  

    Europe  

    Spain  

View report >

Alk - Annual Report, March 2012

  • Alk Releases its Annual Report 2011
  • March 2012
    87 pages
  • Denmark  

    Europe  

View report >

Medigene - Annual Report, 2013

  • Tr Ansformation
  • January 2013
    145 pages
  • Germany  

View report >

Pathology Description in the US

  • Facts Spring 2014
  • April 2014
    28 pages
  • Cancer  

  • United States  

    North America  

View report >
40 reports for Immunotherapy

Purchase Reports From Reputable Market Research Publishers
(From $ 125 - $ 6 813)

Cancer Immunotherapy: immune checkpoint inhibitors, cancer vaccines, and adoptive T-cell therapies

Cancer Immunotherapy: immune checkpoint inhibitors, cancer vaccines, and adoptive T-cell therapies

  • $ 2 495
  • Industry report
  • September 2014
  • by CHI Insight Pharma Reports

This report focuses on the rising potential for the newest and most promising of cancer treatments: cancer immunotherapy. Cancer immunotherapy was once just a dream in the minds of physicians, clinicians ...



ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.